177 related articles for article (PubMed ID: 33548083)
1. Downregulation of SHANK-associated RH domain-interacting protein elevates interleukin-33 expression by stimulating the Janus kinase 2/signal transducer and activator of transcription signalling pathway in HaCaT cells.
Zhang X; Wang J; Zhu J; Liang Y
Clin Exp Dermatol; 2021 Jul; 46(5):880-887. PubMed ID: 33548083
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated SHARPIN may accelerate the development of atopic dermatitis through activating interleukin-33/ST2 signalling.
Tang L; Wang J; Zhu J; Liang Y
Exp Dermatol; 2018 Dec; 27(12):1328-1335. PubMed ID: 30230040
[TBL] [Abstract][Full Text] [Related]
3. Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling.
Dao TTP; Song K; Kim JY; Kim YS
Inflamm Res; 2020 Mar; 69(3):309-319. PubMed ID: 32002586
[TBL] [Abstract][Full Text] [Related]
4. Nuclear IL-33 Plays an Important Role in IL-31‒Mediated Downregulation of FLG, Keratin 1, and Keratin 10 by Regulating Signal Transducer and Activator of Transcription 3 Activation in Human Keratinocytes.
Dai X; Shiraishi K; Muto J; Utsunomiya R; Mori H; Murakami M; Sayama K
J Invest Dermatol; 2022 Jan; 142(1):136-144.e3. PubMed ID: 34293350
[TBL] [Abstract][Full Text] [Related]
5. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis.
Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744
[TBL] [Abstract][Full Text] [Related]
6. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
[TBL] [Abstract][Full Text] [Related]
8. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
Huang IH; Chung WH; Wu PC; Chen CB
Front Immunol; 2022; 13():1068260. PubMed ID: 36569854
[TBL] [Abstract][Full Text] [Related]
9. Janus kinase inhibitors for atopic dermatitis: a promising treatment modality.
Cartron AM; Nguyen TH; Roh YS; Kwatra MM; Kwatra SG
Clin Exp Dermatol; 2021 Jul; 46(5):820-824. PubMed ID: 33484582
[TBL] [Abstract][Full Text] [Related]
10. Naringenin ameliorates atopic dermatitis by inhibiting inflammation and enhancing immunity through the JAK2/STAT3 pathway.
Tian L; Wang M; Wang Y; Li W; Yang Y
Genes Genomics; 2024 Mar; 46(3):333-340. PubMed ID: 37837514
[TBL] [Abstract][Full Text] [Related]
11. Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis.
Scuron MD; Fay BL; Connell AJ; Peel MT; Smith PA
Front Immunol; 2020; 11():620098. PubMed ID: 33658996
[TBL] [Abstract][Full Text] [Related]
12. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors.
Nakashima C; Yanagihara S; Otsuka A
Allergol Int; 2022 Jan; 71(1):40-46. PubMed ID: 34815171
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Invasion of Human Glioblastoma U87 Cell Line by Ruxolitinib: A Molecular Player of miR-17 and miR-20a Regulating JAK/STAT Pathway.
Delen E; Doganlar O; Doganlar ZB; Delen O
Turk Neurosurg; 2020; 30(2):182-189. PubMed ID: 31452174
[TBL] [Abstract][Full Text] [Related]
14. JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy.
Tao J; Mariani L; Eddy S; Maecker H; Kambham N; Mehta K; Hartman J; Wang W; Kretzler M; Lafayette RA
Clin J Am Soc Nephrol; 2020 Jul; 15(7):973-982. PubMed ID: 32354727
[TBL] [Abstract][Full Text] [Related]
15. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis.
Bao L; Shi VY; Chan LS
Mol Immunol; 2012 Feb; 50(1-2):91-7. PubMed ID: 22226123
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation.
Fridman JS; Scherle PA; Collins R; Burn T; Neilan CL; Hertel D; Contel N; Haley P; Thomas B; Shi J; Collier P; Rodgers JD; Shepard S; Metcalf B; Hollis G; Newton RC; Yeleswaram S; Friedman SM; Vaddi K
J Invest Dermatol; 2011 Sep; 131(9):1838-44. PubMed ID: 21677670
[TBL] [Abstract][Full Text] [Related]
17. [MOR106 alleviates inflammation in mice with atopic dermatitis by blocking the JAK2/STAT3 signaling pathway and inhibiting IL-17C-mediated Tfh cell differentiation].
Tian L; Huyan X; Yang S; Wang M; Yang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jan; 40(1):26-32. PubMed ID: 38246174
[TBL] [Abstract][Full Text] [Related]
18. TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways.
Han J; Cai X; Qin S; Zhang Z; Wu Y; Shi Y; Deng T; Chen B; Liu L; Qian H; Fang W; Xiao F
Br J Dermatol; 2023 Jul; 189(2):195-209. PubMed ID: 36928730
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies.
Gong X; Chen X; Kuligowski ME; Liu X; Liu X; Cimino E; McGee R; Yeleswaram S
Am J Clin Dermatol; 2021 Jul; 22(4):555-566. PubMed ID: 33982267
[TBL] [Abstract][Full Text] [Related]
20. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
